Post-Operative Spinal Block Duration and Pain Relief After Hip Replacement Surgery: Comparing Single-Shot Spinal Ropivacaine and Bupivacaine

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity of Turku

About this trial

This study aims to determine whether isobaric ropivacaine is more suitable than isobaric bupivacaine for spinal anesthesia in outpatient total hip arthroplasty (THA). The study will evaluate whether ropivacaine allows faster recovery of sensory and motor function while still providing adequate surgical anesthesia and postoperative pain control. Additional aims are to assess the effects of the anesthetic technique on same-day discharge rates, postoperative recovery, urinary retention, opioid consumption, and patient satisfaction after outpatient THA.

Eligibility criteria

Qualifiers

18 - 80 years of age

Scheduled for a primary elective total hip arthroplasty

Patient must be a candidate for same day discharge

Informed consent understood and signed

Disqualifiers

Scheduled bilateral THA

Contraindication to or failed spinal anesthesia

Allergy or contraindication to NSAIDs (e.g. chronic kidney disease)

Diabetes requiring insulin medication

Trial design

Treatments tested in this trial

  • Spinal Anesthesia with Ropivacaine 15 mg (5 mg/ml)
  • Spinal Anesthesia with Bupivacaine 11 mg (5 mg/ml)

Treatment groups

176 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

University of Turku

Lead sponsor

Turku University Hospital

Collaborator